Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
NeuroPace Inc (NPCE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on NeuroPace Inc|
Txns:
| Sold 7,614 shares
@ $9.08, valued at
$69.1k
Sold 700 shares
@ $9.02, valued at
$6.3k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Ridley Irina (Chief Legal Officer/Secretary) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Morrell Martha (Chief Medical Officer) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 01/09/2023 |
4
| Geiger Uri (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 120,521 options to buy
@ $1.535, valued at
$185k
|
|
| 11/23/2022 |
4
| Accelmed Partners II L.P. (10% Owner) has filed a Form 4 on NeuroPace Inc|
Txns:
| Bought 327,893 shares
@ $1.499, valued at
$491.5k
Bought 62,398 shares
@ $1.499, valued at
$93.5k
|
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Morrell Martha (Chief Medical Officer) has filed a Form 4 on NeuroPace Inc|
Txns:
| Exercised 192 options to buy
@ $0.026, valued at
$5
Exercised 384 options to buy
@ $0.026, valued at
$10 |
|
| 06/21/2022 |
4
| Andrade Lisa (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 18,253 options to buy
@ $6.3, valued at
$115k
|
|
| 06/21/2022 |
4
| Fischer Frank M (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 18,253 options to buy
@ $6.3, valued at
$115k
|
|
| 06/21/2022 |
4
| Garfield Greg Shaw (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 18,253 options to buy
@ $6.3, valued at
$115k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 155,080 shares
@ $0
Granted 310,160 options to buy
@ $8.1, valued at
$2.5M
|
|
| 03/07/2022 |
4
| Ridley Irina (General Counsel and Secretary) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 56,987 shares
@ $0
Granted 83,530 options to buy
@ $8.15, valued at
$680.8k
|
|
| 03/07/2022 |
4
| Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 46,740 shares
@ $0
Granted 93,480 options to buy
@ $8.15, valued at
$761.9k
|
|
| 03/07/2022 |
4
| Morrell Martha (Chief Medical Officer) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 46,760 shares
@ $0
Granted 93,530 options to buy
@ $8.15, valued at
$762.3k
|
|
| 03/01/2022 |
4
| Ridley Irina (General Counsel and Secretary) has filed a Form 4 on NeuroPace Inc|
Txns:
| Sold 1,470 shares
@ $7.5386, valued at
$11.1k
|
|
| 11/02/2021 |
4
| Andrade Lisa (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 11,836 options to buy
@ $15.63, valued at
$185k
|
|
| 10/08/2021 |
4
| Ryan Renee (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 21,698 options to buy
@ $17, valued at
$368.9k
|
|
| 10/08/2021 |
4
| Norton Evan (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 21,698 options to buy
@ $17, valued at
$368.9k
|
|
| 10/08/2021 |
4
| Kumar Rakhi (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 21,698 options to buy
@ $17, valued at
$368.9k
|
|
| 10/08/2021 |
4
| LACOB JOSEPH (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 21,698 options to buy
@ $17, valued at
$368.9k
|
|
| 06/08/2021 |
4
| Morrell Martha (Chief Medical officer) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 8,181 shares
@ $0
Granted 16,363 options to buy
@ $21.67, valued at
$354.6k
|
|
| 06/08/2021 |
4
| Favet Michael (CEO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 26,590 shares
@ $0
Granted 53,180 options to buy
@ $21.67, valued at
$1.2M
|
|
| 06/08/2021 |
4
| Kuhn Rebecca (CFO) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 8,181 shares
@ $0
Granted 16,363 options to buy
@ $21.67, valued at
$354.6k
|
|
| 06/08/2021 |
4
| Ridley Irina (General Counsel and Secretary) has filed a Form 4 on NeuroPace Inc|
Txns:
| Granted 5,681 shares
@ $0
Granted 11,363 options to buy
@ $21.67, valued at
$246.2k
|
|
| 04/26/2021 |
4
| Fischer Frank M (Director) has filed a Form 4 on NeuroPace Inc|
Txns:
| Converted 472,366 shares
@ $0
Converted 21,486 options to buy
@ $0
Converted 450,880 options to buy
@ $0 |
|
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|